1.The Effect of Bone Immune Microenvironment and Bone Mesenchymal Stem Cells on the Heterotopic Ossification of Ankylosing Spondylitis Based on the Theory of "Bone Sweat Pore-Kidney Visceral Manifestation"
Journal of Traditional Chinese Medicine 2025;66(2):128-132
Heterotopic ossification is an important pathological link leading to disability in ankylosing spondylitis (AS). Imbalance of bone immune microenvironment is the initiating factor for heterotopic ossification in AS, while abnormal osteogenic potential of bone marrow mesenchymal stem cells (BMSCs) is the core link. From the perspective of "bone sweat pore-kidney visceral manifestation" in traditional Chinese medicine, it is believed that dysfunction of "kidney visceral manifestation" is the basis for the induction of heterotopic ossification by bone immune microenvironment and BMSCs, and "bone sweat pore" is their important setting. Accordingly, it is proposed that the kidney and sweat pore should be nourished and regulated to reshape the bone immune microenvironment and BMSCs function, and that obstruction should be removed and the marrow should be unblocked to eliminate the pathological factors that lead to AS heterotopic ossification. This provides a new perspective and basis for the treatment of AS with traditional Chinese medicine.
2.Mechanism of heterotopic ossification in ankylosing spondylitis:research progress
Yuening CHEN ; Qing YU ; Hongxiao LIU
Academic Journal of Naval Medical University 2024;45(12):1553-1560
Ankylosing spondylitis is a refractory autoimmune disease,and heterotopic ossification is one of the most important pathological features.The mechanism of heterotopic ossification in ankylosing spondylitis involves many aspects,including ossification-related genes,ossification-related factors,ossification-related cells,ossification signaling pathways,and mechanical stress.This article elaborates the pathogenesis of heterotopic ossification in ankylosing spondylitis from different aspects of multiple channels,pathways,targets,and factors,hoping to provide reference for expanding clinical and basic research and in-depth understanding of ankylosing spondylitis.
3.Treatment of Gastric Ulcer in Active Stage with Carbuncle Theory in Toxicity-heat Theory Based on "State-target Medicine"
Liming CHEN ; Guozheng LIU ; Shuo YANG ; Yan LI ; Yangyang SUN ; Yuening BIAN ; Yilin ZHAO ; Jingdong XIAO
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(18):217-227
"State-target medicine" is a traditional Chinese medicine (TCM) diagnosis and treatment theoretical system proposed by Academician Tong Xiaolin based on the current development of modern medicine. The active stage of gastric ulcer, as a precancerous state of gastric cancer, has a great impact on people's health. Prof. ZHOU Xuewen, a master of TCM, innovatively put forward the theory of "toxicity-heat" etiology for the active stage of gastric ulcer, which plays an important guiding role in clinical diagnosis and treatment. The article took the theoretical system of "state-target medicine" as the framework to explain the rationale, method, formula, and medicine of Prof. ZHOU Xuewen, who applied the Xiaoyong Kuidekang based on the "toxicity-heat" theory to treat the gastric ulcer in the active stage. The Chinese medical name of gastric ulcer, "gastric carbuncle", was established, and it was believed that gastric ulcer is born due to "toxicity" and is based on "toxicity and heat". In the course of the disease, "toxicity", "heat", "deficiency", and "stasis" coexisted, and its pathogenesis was divided into three phases, namely, toxicity-heat accumulation phase, toxicity-heat affecting the health phase, and weakened body resistance and strengthened toxicity phase. According to the positioning of gastric ulcer as an "internal carbuncle", Prof. ZHOU Xuewen proposed the treatment of gastric ulcer in the active stage with "carbuncle theory" and introduced the surgical methods of "elimination", "support", and "tonifying" into the treatment of gastric ulcer in the active stage. Prof. ZHOU Xuewen took "clearing heat and removing toxins, eliminating carbuncle and generating muscle" as the basic treatment of the disease. For different stages of the disease, Prof. ZHOU Xuewen emphasized the use of the methods of clearing heat and removing toxins, supporting rot and muscle growth, and strengthening the spleen and harmonizing the stomach and created the representative formula for the treatment of gastric ulcer in the active stage with "carbuncle theory", namely "Xiaoyong Kuidekang", which could regulate state and targets.
4.Increased expression of coronin-1a in amyotrophic lateral sclerosis: a potential diagnostic biomarker and therapeutic target.
Qinming ZHOU ; Lu HE ; Jin HU ; Yining GAO ; Dingding SHEN ; You NI ; Yuening QIN ; Huafeng LIANG ; Jun LIU ; Weidong LE ; Sheng CHEN
Frontiers of Medicine 2022;16(5):723-735
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease. At present, no definite ALS biomarkers are available. In this study, exosomes from the plasma of patients with ALS and healthy controls were extracted, and differentially expressed exosomal proteins were compared. Among them, the expression of exosomal coronin-1a (CORO1A) was 5.3-fold higher than that in the controls. CORO1A increased with disease progression at a certain proportion in the plasma of patients with ALS and in the spinal cord of ALS mice. CORO1A was also overexpressed in NSC-34 motor neuron-like cells, and apoptosis, oxidative stress, and autophagic protein expression were evaluated. CORO1A overexpression resulted in increased apoptosis and oxidative stress, overactivated autophagy, and hindered the formation of autolysosomes. Moreover, CORO1A activated Ca2+-dependent phosphatase calcineurin, thereby blocking the fusion of autophagosomes and lysosomes. The inhibition of calcineurin activation by cyclosporin A reversed the damaged autolysosomes. In conclusion, the role of CORO1A in ALS pathogenesis was discovered, potentially affecting the disease onset and progression by blocking autophagic flux. Therefore, CORO1A might be a potential biomarker and therapeutic target for ALS.
Mice
;
Animals
;
Amyotrophic Lateral Sclerosis/pathology*
;
Calcineurin/metabolism*
;
Motor Neurons/pathology*
;
Microfilament Proteins/metabolism*
;
Cytoskeletal Proteins/metabolism*